S. Thangaratinam

First name

S.

Last name

Thangaratinam

Lee, S. I., Hope, H., O'Reilly, D., Kent, L., Santorelli, G., Subramanian, A., et al. (2023). Maternal and child outcomes for pregnant women with pre-existing multiple long-term conditions: protocol for an observational study in the UK. Bmj Open, 13, e068718. http://doi.org/10.1136/bmjopen-2022-068718

View

Subramanian, A., Azcoaga-Lorenzo, A., Anand, A., Phillips, K., Lee, S. I., Cockburn, N., et al. (2023). Polypharmacy during pregnancy and associated risk factors: a retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000-2019. Bmc Med, 21, 21. http://doi.org/10.1186/s12916-022-02722-5

View

Wambua, S., Crowe, F., Thangaratinam, S., O'Reilly, D., McCowan, C., Brophy, S., et al. (2022). Protocol for development and validation of postpartum cardiovascular disease (CVD) risk prediction model incorporating reproductive and pregnancy-related candidate predictors. Diagn Progn Res, 6, 23. http://doi.org/10.1186/s41512-022-00137-7

View

Subramanian, A., Lee, S. I., Phillips, K., Toulis, K. A., Kempegowda, P., O'Reilly, M. W., et al. (2022). Polycystic ovary syndrome and risk of adverse obstetric outcomes: a retrospective population-based matched cohort study in England. Bmc Med, 20, 298. http://doi.org/10.1186/s12916-022-02473-3

View

Lee, S. I., Azcoaga-Lorenzo, A., Agrawal, U., Kennedy, J. I., Fagbamigbe, A. F., Hope, H., et al. (2022). Epidemiology of pre-existing multimorbidity in pregnant women in the UK in 2018: a population-based cross-sectional study. Bmc Pregnancy Childbirth, 22, 120. http://doi.org/10.1186/s12884-022-04442-3

View